PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors.
Abu Sabbah T, Theurer S, Baba HA, Lueong S, Rashidi-Alavijeh J, Hilser T, Zaun Y, Metzenmacher M, Pogorzelski M, Virchow I, Pretzell I, Kostbade K, Treckmann J, Wiesweg M, Schuler M, Kasper S, Zaun G.
Abu Sabbah T, et al. Among authors: rashidi alavijeh j.
Eur J Cancer. 2024 Oct;210:114268. doi: 10.1016/j.ejca.2024.114268. Epub 2024 Aug 10.
Eur J Cancer. 2024.
PMID: 39153343
Free article.